Minnesota’s early season performance has been a mixed bag, leaving fans scratching their heads and analysts mulling over what to expect as the season unfolds. At the same time, there are some reasons ...

Significant losses in leading IT stocks such as Tata Consultancy Services (TCS), Infosys, Wipro, HCL Technologies, and ...

The FDA approved Amgen's Uplizna as the first treatment for IgG4-RD. The decision is backed by the MITIGATE trial, showing reduced flares and sustained efficacy.

Amgen (NASDAQ:AMGN) announced today that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA as the first and onl ...

Sanofi's rilzabrutinib receives FDA orphan drug designation for two rare diseases. Clinical studies show meaningful response ...

Dun & Bradstreet and SIDBI release the SPeX, or 'Green Pulse Indicator', assessing MSME's sustainability perception across willingness, awareness, and implementation. Despite a 5.3% decline in Q4 2024 ...

Chart review has mostly been a manual process, has been prone to error, and is an area where extracting actionable insights ...

Monitoring and interpreting these essential financial metrics can provide invaluable insights into the fiscal health and ...

I was out for a jog, and the next, I was searching “best shoes for plantar fasciitis,” the suspected cause of my sudden heel ...

Cloudflare (NET) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider ...

Cloudflare stock is up 50% since the start of 2024 but down 27% since mid-February.

Cloudflare is aggressively investing in AI, prioritizing long-term growth over near-term profitability. Read why I remain ...